Maria Vonotna November was a month to remember for biotech stocks as gene therapy developers outperformed and pharma giants looked…
- hello@whatnews.in
Browsing: outlook
nielubieklonu/iStock via Getty Images Noble Corp. (NYSE:NE) +1.2% in Friday’s trading as Susquehanna initiated coverage with a Neutral rating and…
Investors will need to be tactical to harvest returns from commodities next year but there is an area where J.P.…
Consumption-oriented software businesses have experienced a tough recent stretch, but Snowflake Inc. is winning cheers Thursday for showing signs of…
2023 Outlook: Academy is narrowing its guidance for fiscal 2023 as follows: Net sales of $6,110M-$6170M vs. the consensus of…
Barclays (LON:) has expressed confidence in the financial trajectory of Marks & Spencer, the renowned British retailer, by raising its…
PVH Corp. (NYSE:) shares fell more than 5% after-hours despite the company’s reporting Q3 earnings, with EPS of $2.90 beating…
Investing.com — The economic outlook soured on slowing growth in recent weeks as consumers are keeping a closer on spending…
Deutsche Bank (ETR:) has adjusted its outlook on AXA, increasing the price target to €34 from the previous €30.5. This…
Palantir recently hit two-year highs at $21.85, fueled by positive factors like government revenue, and a $1 billion buyback program…